拉丁美洲和加勒比地区的通用药和生物仿制药的知识,感知和利用:一个范围审查
Bernardo Aguilera1, Sebastián Peña2,3, Juan Pablo Morales4
1UNIVERSIDAD SAN SEBASTIÁN, SANTIAGO, CHILE.
本综述绘制了拉丁美洲和加勒比地区 (LAC) 的医疗保健专业人员和患者对仿制药和生物仿制药的知识和看法. 它研究了这些因素如何影响低成本药物的使用.
科学领域:
- 制药科学 制药科学
- 卫生政策 卫生政策
- 公共卫生 公共卫生
背景情况:
- 仿制药和生物仿制药为原始产品提供了具有成本效益的替代品.
- 了解利益相关者的知识和看法对于有效实施政策至关重要.
- 拉丁美洲和加勒比地区 (LAC) 在药品获取和利用方面面临着独特的挑战.
研究的目的:
- 绘制和批判性地检查仿制药和生物类似药的知识,感知和利用情况.
- 确定在LAC地区采用仿制药和生物类似药的障碍和促进因素.
- 为改善适当使用这些重要药物的战略提供信息.
主要方法:
- 采用了一种全面的范围审查方法.
- 在多个数据库中进行文献搜索.
- 数据被合成,以确定与知识,感知和利用相关的关键主题.
主要成果:
- 在各利益相关者群体中发现了对仿制药和生物类似药的知识和理解水平的变化.
- 感知范围从积极的接受到怀疑和担忧.
- 使用模式受到处方者信心,患者信任和监管框架等因素的影响.
结论:
- 需要有针对性的教育倡议,以提高对仿制药和生物类似药的理解,在LAC地区的所有利益相关者之间.
- 解决误解和建立信任对于增加这些药物的适当使用至关重要.
- 政策干预应考虑区域特点,以促进公平获得负担得起的疗法.
更多相关视频
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
07:35A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
相关概念视频
Bioequivalence: Overview
Drug Control Governance: Regulatory Bodies and Their Impact
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Biopharmaceutics and Pharmacokinetics: Overview
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
